undamentalytics Newsletter

Codexis vs Mdxhealth SA

Mdxhealth SA is the larger business, with $108m of revenue in fiscal 2025 against $70.4m for Codexis (1.5 times as much). Mdxhealth SA grew faster (19.8% against 18.6%). Mdxhealth SA kept more of each dollar of sales as profit: a net margin of -31.1% against -62.5%.

Latest fiscal yearCodexisCDXS, 2025Mdxhealth SAMDXH, 2025
Revenue $70.4m $108m
Revenue growth 18.6% 19.8%
Net income −$44.0m −$33.5m
Operating margin -59.3% -13.4%
Net margin -62.5% -31.1%
Return on equity -74.9% —
Free cash flow −$23.8m −$3.3m
Cash $50.8m $29.0m
Total debt $42.2m $76.2m
Debt to equity 83.4% —
Dividend per share — —
Dividend yield — —
Share buybacks — —
Employees 146 —
Market value $97.3m $7.9m
Price vs our value range — —
Moat score 23 (Weak) —
Insider trades, 12 months 0 buys, 37 sales 1 buys, 0 sales

Each figure is from the company's latest annual report and links to the page it comes from. Fiscal years can end on different dates. Market value and the value verdict use the delayed price shown on the stock pages. Not a recommendation.

Go deeper

Figures from each company's latest annual report filed with the SEC (10-K or 20-F), as reported, with the fiscal year shown. Not investment advice. How we read filings: methodology.